Shanghai Jiaolian Drug Research and Development Co., Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-20
ACTIVE TRIALS5
PHASE 3 / 2-34
RECRUITING5
READOUTS ≤12 MONTHS5
READOUT SLIPPED >6 MO20%
Delay Index: of 5 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →
Open Shanghai Jiaolian Drug Research and Development Co., Ltd on the live radar map →| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| B007 NCT06447597 |
P2/3 | Recruiting | Generalized Myasthenia Gravis | 104 | 2026-12-30 (+6 mo) |
| B007 NCT06470191 |
P2/3 | Recruiting | Primary Membranous Nephropathy | 216 | 2026-12-31 |
| B013 NCT06434610 |
P2 | Recruiting | Platinum-resistant Recurrent Ovarian Cancer | 90 | 2026-12-31 |
| B007 NCT06454357 |
P2/3 | Recruiting | Pemphigus | 132 | 2026-12-31 |
| B001 NCT06413654 |
P2/3 | Recruiting | Neuromyelitis Optica Spectrum Disorders | 132 | 2027-10-31 |